|
1
|
Sansotta N, Peroni DG, Romano S, Rugiano
A, Vuilleumier P and Baviera G: Italian Society of Pediatric
Allergy, Immunology (SIAIP), Microbiota Committee, Italy. The good
bugs: The use of probiotics in pediatrics. Curr Opin Pediatr.
31:661–669. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bantz SK, Zhu Z and Zheng T: The atopic
march: Progression from atopic dermatitis to allergic rhinitis and
asthma. J Clin Cell Immunol. 5(202)2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bumbăcea RS, Deaconu CG and Berghea EC:
Management problems in severe chronic inducible urticaria: Two case
reports. Exp Ther Med. 18:960–963. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bumbacea R, Berghea E and Giurcaneanu C:
Frequency of contact sensitisation in children with atopic
dermatitis. Allergy. 62 (Suppl 83)(S319)2007.
|
|
5
|
Eichenfield LF, Tom WL, Chamlin SL,
Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen
DE, Cooper KD, et al: Guidelines of care for the management of
atopic dermatitis: Section 1. Diagnosis and assessment of atopic
dermatitis. J Am Acad Dermatol. 70:338–351. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
No authors listed. Worldwide variation in
prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and
atopic eczema: ISAAC The International Study of Asthma and
Allergies in Childhood (ISAAC) Steering Committee. Lancet.
351:1225–1232. 1998.PubMed/NCBI
|
|
7
|
Rather IA, Bajpai VK, Kumar S, Lim J, Paek
WK and Park YH: Probiotics and atopic dermtitis: An overview. Front
Microbiol. 7(507)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Monti F, Agostini F, Gobbi F, Neri E,
Schianchi S and Arcangeli F: Quality of life measures in Italian
children with atopic dermatitis and their families. Ital J Pediatr.
37(59)2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chernyshov PV, Sampogna F, Pustišek N,
Marinovic B, Manolache L, Suru A, Salavastru CM, Tiplica GS,
Stoleriu G, Kakourou T, et al: Validation of the
dermatology-specific proxy instrument the infants and toddlers
dermatology quality of life. J Eur Acad Dermatol Venereol.
33:1405–1411. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kim NY and Ji GE: Effects of probiotics on
the prevention of atopic dermatitis. Korean J Pediatr. 55:193–201.
2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Solomon I, Ilie MA, Draghici C, Voiculescu
VM, Caruntu C, Boda D and Zurac S: The impact of lifestyle factors
on evolution of atopic dermatitis: An alternative approach. Exp
Ther Med. 17:1078–1084. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bumbacea RS, Corcea SL, Ali S, Dinica LC,
Fanfaret IS and Boda D: Mite allergy and atopic dermatitis: Is
there a clear link? (Review). Exp Ther Med. 20:3554–3560.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Meneghin F, Fabiano V, Mameli C and
Zuccotti GV: Probiotics and atopic dermatitis in children.
Pharmaceuticals (Basel). 5:727–744. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bjorksten B: The intrauterine and
postnatal environments. J Allergy Clin Immunol. 104:1119–1127.
1999.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ro ADB, Simpson MR, Rø TB, Storrø O,
Johnsen R, Videm V and Øien T: Reduced Th22 cell proportion and
prevention of atopic dermatitis in infants following maternal
probiotic supplementation. Clin Exp Allergy. 47:1014–1021.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Strachan DP: Hay fever, hygiene, and
household size. BMJ. 299:1259–1260. 1989.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Strachan DP: Family size, infection and
atopy: The first decade of the ‘hygiene hypothesis’. Thorax. 55
(Suppl 1):S2–S10. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Prescott SL, Macaubas C, Holt BJ,
Snallacombe TB, Loh R, Sly PD and Holt PG: Transplacental priming
of the human immune system to environmental allergens: Universal
skewing of initial T cell responses toward the Th2 cytokine
profile. J Immunol. 160:4730–4737. 1998.PubMed/NCBI
|
|
19
|
Kopp MV, Zehle C, Pichler J, Szépfalusi Z,
Moseler M, Deichmann K, Forster J and Kuehr J: Allergen-specific T
cell reactivity in cord blood: The influence of maternal cytokine
production. Clin Exp Allergy. 31:1536–1543. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Prescott SL, Macaubas C, Smallacombe T,
Holt BJ, Sly PD and Holt PG: Development of allergen-specific
T-cell memory in atopic and normal children. Lancet. 353:196–200.
1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo
C and Koga Y: The requirement of intestinal bacterial flora for the
development of an IgE production system fully susceptible to oral
tolerance induction. J Immunol. 159:1739–1745. 1997.PubMed/NCBI
|
|
22
|
Riedler J, Braun-Fahrlander C, Eder W,
Schreuer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D and von
Mutius E: ALEX Study Team. Exposure to farming in early life and
development of asthma and allergy: A cross-sectional survey.
Lancet. 358:1129–1133. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Taylor AL, Dunstan JA and Prescott SL:
Probiotic supplementation for the first 6 months of life fails to
reduce the risk of atopic dermatitis and increases the risk of
allergen sensitization in high-risk children: A randomized
controlled trial. J Allergy Clin Immunol. 119:184–191.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Williams H, Robertson C, Stewart A,
Aït-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Björkstén
B, Burr M, et al: Worldwide variations in the prevalence of
symptoms of atopic eczema in the International study of asthma and
allergies in childhood. J Allergy Clin Immunol. 103:125–138.
1999.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Brandt EB and Sivaprasad U: Th2 cytokines
and atopic dermatitis. J Clin Cell Immunol. 2(110)2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kubo A, Nagao K and Amagai M: Epidermal
barrier dysfunction and cutaneous sensitization in atopic diseases.
J Clin Invest. 122:440–447. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Candela M, Rampelli S, Turroni S,
Severgnini M, Consolandi C, De Bellis G, Masetti R, Ricci G,
Pession A and Brigidi P: Unbalance of intestinal microbiota in
atopic children. BMC Microbiol. 12(95)2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Penders J, Stobberingh EE, van den Brandt
PA and Thijs C: The role of the intestinal microbiota in the
development of atopic disorders. Allergy. 62:1223–1236.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Baker BS: The role of microorganisms in
atopic dermatitis. Clin Exp Immunol. 144:1–9. 2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kunz B, Oranje AP, Labrèze L, Stalder JF,
Ring J and Taïeb A: Clinical validation and guidelines for the
SCORAD index: Consensus report of the European task force on atopic
dermatitis. Dermatology. 195:10–19. 1997.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Guarner F and Schaafsma GJ: Probiotics.
Int J Food Microbiol. 39:237–238. 1998.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Van Santvoort HC, Besselink MG, Timmerman
HM, van Minnen LP, Akkermans LM and Gooszen HG: Probiotics in
surgery. Surgery. 143:1–7. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Frei R, Akdis M and O'Mahony L:
Prebiotics, probiotics, synbiotics, and the immune system:
Experimental data and clinical evidence. Curr Opin Gastroenterol.
31:153–158. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Enomoto T, Sowa M, Nishimori K, Shimazu S,
Yoshida A, Yamada K, Furukawa F, Nakagawa T, Yanagisawa N, Iwabuchi
N, et al: Effects of bifidobacterial supplementation to pregnant
women and infants in the prevention of allergy development in
infants and on fecal microbiota. Allergol Int. 63:575–585.
2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rusu E, Enache G, Cursaru R, Alexescu A,
Radu R, Onila O, Cavallioti T, Rusu F, Posea M, Jinga M and
Radulian G: Prebiotics and probiotics in atopic dermatitis. Exp
Ther Med. 18:926–931. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Borchers AT, Selmi C, Meyers FJ, Keen CL
and Gershwin ME: Probiotics and immunity. J Gastroenterol.
44:26–46. 2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Alvarez-Olmos MI and Oberhelman RA:
Probiotic agents and infectious diseases: A modern perspective on a
traditional therapy. Clin Infect Dis. 32:1567–1576. 2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Roberfroid M, Gibson GR, Hoyles L,
McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska
H, Stahl B, et al: Prebiotic effects: Metabolic and health
benefits. Br J Nutr. 104 (Suppl 2):S1–S63. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Passeron T, Lacour JP, Fontas E and
Ortonne JP: Prebiotics and synbiotics: Two promising approaches for
the treatment of atopic dermatitis in children above 2 years.
Allergy. 61:431–437. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gibson GR and Roberfroid MB: Dietary
modulation of the human colonic microbiota: Introducing the concept
of prebiotics. J Nutr. 125:1401–1412. 1995.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Maslowski KM, Vieira AT, Ng A, Kranich J,
Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, et al:
Regulation of inflammatory responses by gut microbiota and
chemoattractant receptor GPR43. Nature. 461:1282–1286.
2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
De Preter V, Geboes K, Verbrugghe K, De
Vuyst L, Vanhoutte T, Huys G, Swings J, Pot B and Verbeke K: The in
vivo use of the stable isotope-labelled biomarkers
lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro-
and prebiotics on the intestinal flora of healthy human volunteers.
Br J Nutr. 92:439–446. 2004.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Schley PD and Field CJ: The
immune-enhancing effects of dietary fibres and prebiotics. Br J
Nutr. 87 (Suppl 2):S221–S230. 2002.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Moro G, Minoli I, Mosca M, Fanaro S,
Jelinek J, Stahl B and Boehm G: Dosage-related bifidogenic effects
of galactoand fructooligosaccharides in formula-fed term infants. J
Pediatr Gastroenterol Nutr. 34:291–295. 2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Haarman M and Knol J: Quantitative
real-time PCR assays to identify and quantify fecal Bifidobacterium
species in infants receiving a prebiotic infant formula. Appl
Environ Microbiol. 71:2318–2324. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Schmelzle H, Wirth S, Skopnik H, Radke M,
Knol J, Böckler HM, Brönstrup A, Wells J and Fusch C: Randomized
double-blind study of the nutritional efficacy and bifidogenicity
of a new infant formula containing partially hydrolyzed protein, a
high beta-palmitic acid level, and nondigestible oligosaccharides.
J Pediatr Gastroenterol Nutr. 36:343–351. 2003.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kovacs Z, Benjamins E, Grau K, Ur Rehman
A, Ebrahimi M and Czermak P: Recent developments in manufacturing
oligosaccharides with prebiotic functions. Adv Biochem Eng
Biotechnol. 143:257–295. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Blaser MJ: The microbiome revolution. J
Clin Invest. 124:4162–4165. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gerlich J, Benecke N, Peters-Weist AS,
Heinrich S, Roller D, Genuneit J, Weinmayr G, Windstetter D,
Dressel H, Range U, et al: Pregnancy and perinatal conditions and
atopic disease prevalence in childhood and adulthood. Allergy.
73:1064–1074. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Huang YJ, Marsland BJ, Bunyavanich S,
O'Mahony L, Leung DY, Muraro A and Fleisher TA: The microbiome in
allergic disease: Current understanding and future
opportunities-2017 PRACTALL document of the American academy of
allergy, asthma & immunology and the European academy of
allergy and clinical immunology. J Allergy Clin Immunol.
139:1099–1110. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Di Gangi A, Di Cicco ME, Comberiati P and
Peroni DG: Go with your gut: The shaping of T-cell response by gut
microbiota in allergic asthma. Front Immunol.
11(1485)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Maslowski KM and Mackay CR: Diet, gut
microbiota and immune responses. Nat Immunol. 12:5–9.
2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Gray LE, O'Hely M, Ranganathan S, Sly PD
and Vuillermin P: The maternal diet, gut bacteria, and bacterial
metabolites during pregnancy influence offspring asthma. Front
Immunol. 8(365)2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kong HH, Oh J, Deming C, Conlan S, Grice
EA, Beatson MA, Nomicos E, Polley EC and Komarow HD: NISC
Comparative Sequence Program. et al: Temporal shifts in the skin
microbiome associated with disease flares and treatment in children
with atopic dermatitis. Genome Res. 22:850–859. 2012.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Lunjani N, Satitsuksanoa P, Lukasik Z,
Sokolowska M, Eiwegger T and O'Mahony L: Recent developments and
highlights in mechanisms of allergic diseases: Microbiome. Allergy.
73:2314–2327. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Swanson KS, Gibson GR, Hutkins R, Reimer
RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM
and Sanders ME: The International scientific association for
probiotics and prebiotics (ISAPP) consensus statement on the
definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol.
17:687–701. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Sommacal HM, Bersch VP, Vitola SP and
Osvaldt AB: Perioperative synbiotics decrease postoperative
complications in periampullary neoplasms: A randomized,
double-blind clinical trial. Nutr Cancer. 67:457–462.
2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Stenman LK, Lehtinen MJ, Meland N,
Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R,
Lähdeaho ML, Linros J, et al: Probiotic with or without fiber
controls body fat mass, associated with serum zonulin, in
overweight and obese adults-randomized controlled trial.
EBioMedicine. 13:190–200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Aldaghi M, Tehrani H, Karrabi M, Abadi FS
and Sahebkar M: The effect of multistrain synbiotic and vitamin D3
supplements on the severity of atopic dermatitis among infants
under 1 year of age: A double-blind, randomized clinical trial
study. J Dermatolog Treat 1-6, 2020 (Epub ahead of print).
|
|
60
|
Dissanayake E, Tani Y, Nagai K, Sahara M,
Mitsuishi C, Togawa Y, Suzuki Y, Nakano T, Yamaide F, Ohno H and
Shimojo N: Skin care and synbiotics for prevention of atopic
dermatitis or food allergy in newborn infants: A 2 x 2 factorial,
randomized, non-treatment controlled trial. Int Arch Allergy
Immunol. 180:202–211. 2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Isolauri E, Arvola T, Sutas Y, Moilanen E
and Salminen S: Probiotics in the management of atopic eczema. Clin
Exp Allergy. 30:1604–1610. 2000.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Weston S, Halbert A, Richmond P and
Prescott SL: Effects of probiotics on atopic dermatitis: A
randomised controlled trial. Arch Dis Child. 90:892–897.
2005.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Smits HH, Engering A, van der Kleij D, de
Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M,
Wierenga EA, van Kooyk Y and Kapsenberg ML: Selective probiotic
bacteria induce IL-10-producing regulatory T cells in vitro by
modulating dendritic cell function through dendritic cell-specific
intercellular adhesion molecule 3-brabbing nonintegrin. J Allergy
Clin Immunol. 115:1260–1267. 2005.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Lesiak A, Smolewski P, Sobolewska-Sztychny
D, Sysa-Jedrzejowska A and Narbutt J: The role of T regulatory
cells and Toll-like receptors 2 and 4 in atopic dermatitis. Scand J
Immunol. 76:405–410. 2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Marlow G, Han DY, Wickens K, Stanley T,
Crane J, Mitchell EA, Dekker J, Barthow C, Fitzharris P, Ferguson
LR and Morgan AR: Differential effects of two probiotics on the
risks of eczema and atopy associated with single nucleotide
polymorphisms to Toll-like receptors. Pediatr Allergy Immunol.
26:262–271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Bode L: The functional biology of human
milk oligosaccharides. Early Hum Dev. 91:619–622. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Ruiz-Palacios GM, Cervantes LE, Ramos P,
Chavez-Munguia B and Newburg DS: Campylobacter Jejuni binds
intestinal H (O) antigen (Fuc alpha1, 2Gal beta1, 4GlcNAc), and
fucosyloligosaccharides of human milk inhibit its binding and
infection. J Biol Chem. 278:14112–14120. 2003.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Manthey CF, Autran CA, Eckmann L and Bode
L: Human milk oligosaccharides protect against enteropathogenic
Escherichia. coli attachment in vitro and EPEC colonization in
suckling mice. J Pediatr Gastroenterol Nutr. 58:167–170.
2014.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Jantscher-Krenn E, Lauwaet T, Bliss LA,
Reed SL, Gillin FD and Bode L: Human milk oligosaccharides reduce
Entamoeba histolytica attachment and cytotoxicity in vitro. Br J
Nutr. 108:1839–1846. 2012.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Angeloni S, Ridet JL, Kusy N, Gao H,
Crevoisier F, Guinchard S, Kochhar S, Sigrist H and Sprenger N:
Glycoprofiling with micro-arrays of glycoconjugates and lectins.
Glycobiology. 15:31–41. 2005.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Eiwegger T, Stahl B, Haidl P, Schmitt J,
Boehm G, Dehlink E, Urbanek R and Szépfalusi Z: Prebiotic
oligosaccharides: In vitro evidence for gastrointestinal epithelial
transfer and immunomodulatory properties. Pediatr Allergy Immunol.
21:1179–1188. 2010.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Vos AP, Haarman M, van Ginkel JW, Knol J,
Garssen J, Stahl B, Boehm G and M'Rabet L: Dietary supplementation
of neutral and acidic oligosaccharides enhances Th1-dependent
vaccination responses in mice. Pediatr Allergy Immunol. 18:304–312.
2007.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Bode L, Kunz C, Muhly-Reinholz M, Mayer K,
Seeger W and Rudloff S: Inhibition of monocyte, lymphocyte, and
neutrophil adhesion to endothelial cells by human milk
oligosaccharides. Thromb Haemost. 92:1402–1410. 2004.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Bode L, Rudloff S, Kunz C, Strobel S and
Klein N: Human milk oligosaccharides reduce platelet-neutrophil
complex formation leading to a decrease in neutrophil beta 2
integrin expression. J Leukoc Biol. 76:820–826. 2004.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhao M, Shen C and Ma L: Treatment
efficacy of probiotics on atopic dermatitis, zooming in on infants:
A systematic review and meta-analysis. Int J Dermatol. 57:635–641.
2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Niccoli AA, Artesi AL, Candio F,
Ceccarelli S, Cozzali R, Ferraro L, Fiumana D, Mencacci M, Morlupo
M, Pazzelli P, et al: Preliminary results on clinical effects of
probiotic Lactobacillus salivarius LSO1 in children affected by
atopic dermatitis. J Clin Gastroenterol. 48 (Suppl 1):S34–S36.
2014.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Rosenfeldt V, Benfeldt E, Nielsen SD,
Michaelsen KF, Jeppesen DL, Valerius NH and Paerregaard A: Effect
of probiotic lactobacillus strains in children with atopic
dermatitis. J Allergy Clin Immunol. 111:389–395. 2003.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Shane AL, Cabana MD, Vidry S, Merenstein
D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch SV, Sanders
ME and Tancredi DJ: Guide to designing, conducting, publishing and
communicating results of clinical studies involving probiotic
applications in human participants. Gut Microbes. 1:243–253.
2010.PubMed/NCBI View Article : Google Scholar
|
